Table 2 Univariate and multivariate analyses of different prognostic parameters in NPC patients
Variables | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
HR | Cl | P | HR | Cl | P | |
OS | ||||||
 Gender | 2.763 | 0.832–9.181 | 0.097 | … | … | … |
 Age | 2.841 | 1.198–6.734 | 0.018 | 5.148 | 1.933–13.707 | 0.001 |
 T stage | 1.317 | 0.554–3.129 | 0.533 | … | … | … |
 N stage | 1.745 | 0.810–3.761 | 0.155 | … | … | … |
 M stage | 9.441 | 3.769–23.647 | <0.001 | 14.195 | 4.642–43.407 | <0.001 |
 Clinical stage | 24.271 | 0.134–4382.908 | 0.229 | … | … | … |
 CIP4 | 1.137 | 1.043–1.240 | 0.004 | 1.111 | 1.015–1.216 | 0.022 |
DMFS | ||||||
 Gender | 4.019 | 0.523–30.911 | 0.181 | … | … | … |
 Age | 1.451 | 0.475–4.436 | 0.514 | … | … | … |
 T stage | 0.666 | 0.218–2.037 | 0.476 | … | … | … |
 N stage | 1.908 | 0.624–5.832 | 0.257 | … | … | … |
 M stage | 13.355 | 4.058–43.955 | <0.001 | 8.565 | 2.495–29.401 | 0.001 |
 Clinical stage | 23.874 | 0.011–53961.801 | 0.421 | … | … | … |
 CIP4 | 1.199 | 1.046–1.374 | 0.009 | 1.159 | 1.006–1.336 | 0.041 |